Literature DB >> 12200517

Psychological consequences of segregation resulting from chronic Burkholderia cepacia infection in adults with CF.

A J A Duff.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12200517      PMCID： PMC1746417          DOI： 10.1136/thorax.57.9.756

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.

Authors:  Karlene H Lynch; Kimberley D Seed; Paul Stothard; Jonathan J Dennis
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

3.  A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo.

Authors:  Slade A Loutet; Ronald S Flannagan; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

Review 4.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Alex Horsley; Andrew M Jones; Robert Lord
Journal:  Cochrane Database Syst Rev       Date:  2016-01-20

5.  Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex.

Authors:  Karlene H Lynch; Paul Stothard; Jonathan J Dennis
Journal:  BMC Genomics       Date:  2010-10-25       Impact factor: 3.969

6.  Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.

Authors:  Abdul Ashish; Matthew Shaw; James McShane; Martin J Ledson; Martin J Walshaw
Journal:  JRSM Short Rep       Date:  2012-02-27

7.  Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis.

Authors:  Janice Abbott; Alison M Morton; Margaret A Hurley; Steven P Conway
Journal:  BMJ Open       Date:  2015-05-19       Impact factor: 2.692

8.  User Preferences and Design Recommendations for an mHealth App to Promote Cystic Fibrosis Self-Management.

Authors:  Marisa E Hilliard; Amy Hahn; Alana K Ridge; Michelle N Eakin; Kristin A Riekert
Journal:  JMIR Mhealth Uhealth       Date:  2014-10-24       Impact factor: 4.773

9.  Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?

Authors:  Alex Horsley; Kevin Webb; Rowland Bright-Thomas; John Govan; Andrew Jones
Journal:  Front Cell Infect Microbiol       Date:  2011-12-21       Impact factor: 5.293

10.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Robert Lord; Andrew M Jones; Alex Horsley
Journal:  Cochrane Database Syst Rev       Date:  2020-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.